These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16848737)

  • 1. Ligand binding domain of vitamin D receptors.
    Rochel N; Moras D
    Curr Top Med Chem; 2006; 6(12):1229-41. PubMed ID: 16848737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids.
    Ikura T; Ito N
    Vitam Horm; 2016; 100():117-36. PubMed ID: 26827950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
    Belorusova AY; Rochel N
    Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor 2016: novel ligands and structural insights.
    Maestro MA; Molnár F; Mouriño A; Carlberg C
    Expert Opin Ther Pat; 2016 Nov; 26(11):1291-1306. PubMed ID: 27454349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Nuclear Receptor Ligands and Elucidation of Their Mechanisms of Action.
    Yamamoto K
    Chem Pharm Bull (Tokyo); 2019; 67(7):609-619. PubMed ID: 31257315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene regulatory potential of nonsteroidal vitamin D receptor ligands.
    Peräkylä M; Malinen M; Herzig KH; Carlberg C
    Mol Endocrinol; 2005 Aug; 19(8):2060-73. PubMed ID: 15860548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25-dihydroxyvitamin D(3) receptor?
    Mohr SC; Swamy N; Xu W; Ray R
    Steroids; 2001; 66(3-5):189-201. PubMed ID: 11179726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minireview: vitamin D receptor: new assignments for an already busy receptor.
    Norman AW
    Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of complexes of vitamin D receptor ligand-binding domain with lithocholic acid derivatives.
    Masuno H; Ikura T; Morizono D; Orita I; Yamada S; Shimizu M; Ito N
    J Lipid Res; 2013 Aug; 54(8):2206-2213. PubMed ID: 23723390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands.
    Carlberg C; Molnár F
    Curr Top Med Chem; 2006; 6(12):1243-53. PubMed ID: 16848738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative binding sites at the vitamin D receptor and their ligands.
    Mutchie TR; Yu OB; Di Milo ES; Arnold LA
    Mol Cell Endocrinol; 2019 Apr; 485():1-8. PubMed ID: 30654005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of vitamin D analogs modulating the pocket structure of vitamin D receptor.
    Yamamoto K; Anami Y; Itoh T
    Curr Top Med Chem; 2014; 14(21):2378-87. PubMed ID: 25537068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
    Mizwicki MT; Bishop JE; Norman AW
    Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand recognition by the vitamin D receptor.
    Choi M; Yamamoto K; Masuno H; Nakashima K; Taga T; Yamada S
    Bioorg Med Chem; 2001 Jul; 9(7):1721-30. PubMed ID: 11425573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.
    Carlberg C; Molnár F
    Can J Physiol Pharmacol; 2015 May; 93(5):311-8. PubMed ID: 25741777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.
    Haussler MR; Jurutka PW; Mizwicki M; Norman AW
    Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
    Rochel N; Hourai S; Pérez-García X; Rumbo A; Mourino A; Moras D
    Arch Biochem Biophys; 2007 Apr; 460(2):172-6. PubMed ID: 17346665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.
    Ciesielski F; Rochel N; Moras D
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):235-42. PubMed ID: 17218092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.